Monday | Rehab Management
ALS Therapy Development Institute Partners with Applied Proteomics,...
The ALS Therapy Development Institute and Applied Proteomics, Inc. announced today that they have completed the first stage of a multi-year collaboration to identify and validate protein biomarkers associated with amyotrophic lateral sclerosis .
Veterans with ALS have new benefits
Sunday, December 13, 2009 at 12:00 p.m. Read more: Local , Community , Health , ALS , Lou Gehrig's Disease , Veterans , Service Related Disablility , Service Connected , Presumptive Condition Onondaga County's Veterans Service Agency is actively looking for veterans--from any service era--who suffer from ALS .A Robert McLean says the vets are ...
The Boulder County Business Report
miRagen suspects drug could treat ALS
BCBR Article miRagen suspects drug could treat ALS By Business Report Staff BOULDER - Researchers discovered miRagen Therapeutics Inc.'s drug miR-206 could be used to treat neuromuscular diseases such as amyotrophic lateral sclerosis.
Molecule Discovery Might Help ALS Patients
Researchers have identified a molecule that can reduce symptoms and prolong the life of mice with a type of amyotrophic lateral sclerosis .
Drug helps muscle in one-third of ALS patients
Nearly a third of amyotrophic lateral sclerosis patients treated with an experimental drug from Sangamo BioSciences Inc had muscle improvement, according to preliminary mid-stage study results announced on Tuesday.
Snapshot Report ) announced that the U.S. Food and Drug Administration lifted a clinical hold on its molecular chaperone candidate arimoclomol for treating patients suffering from amyotrophic lateral sclerosis .
CytRx Announces That FDA Lifts Clinical Hold of Arimoclomol in ALS
CytRx Corporation , a biopharmaceutical company, is permitted to re-enter the clinic with its orally administered molecular chaperone drug candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis , following the U.S. Food and Drug Administration's acceptance of a revised clinical trial protocol.
Heavy metal paradox could point toward new therapy for Lou Gehrig's disease
New discoveries have been made about how an elevated level of lead, which is a neurotoxic heavy metal, can slow the progression of amyotrophic lateral sclerosis, or Lou Gehrig's disease -- findings that could point the way to a new type of therapy.
UMass and biotech firm collaborate on ALS research
A Massachusetts researcher has received a boost for efforts to find a treatment for ALS - or Lou Gehrig's Disease - through the use of gene silencing technology.
Mutated protein contributes to Lou Gehrig's
A new finding by researchers at Hopkins's School of Medicine has elucidated a little-known molecular pathway in the development of amyotrophic lateral sclerosis , or Lou Gehrig's disease.
A Mass of Christian Burial for Kay Hennick Joy, 66, of Hot Springs Village, Ark., will be held 9 a.m. Friday, Dec.
American-Israeli company closes in on ALS treatment
American-Israeli businessman Chaim Lebovits made a fortune with the exploration of gold and other natural resources in Africa before he was persuaded two years ago to buy into a local biotech company.
Neuralstem provides financial and business updates for third-quarter 2009
Neuralstem, Inc. today provided a financial and business update for the third quarter ended September 30, 2009.
New Hope for Neuron Protection
Finding a cure for amyotrophic lateral sclerosis --also known as Lou Gehrig's disease--has been a frustrating and elusive quest.
Woman defies the odds in ALS fight
The words that changed Dick and Deanna's lives forever -- 'Mr. Brekken, this is very serious ... I think she has ALS' -- still ring in Dick Brekken's ears.
Living with Lou Gehrig's Disease: Follow Up
Three months ago, we introduced you to the Kingsbury family. Jim Kingsbury is battling Lou Gehrig's disease.
LIVESHOTS: Is a Cure for ALS Around the Corner?
When New York Yankee Hall of Famer Lou Gehrig died from ALS in 1941 there was no cure.
ALS Treatment Awarded Orphan Drug Designation
Following the provision of clinical and scientific data to the US Food and Drug Administration , privately owned UK company Daval International Limited has been informed that its innovative anti-inflammatory agent AIMSPRO has been awarded an Orphan-Drug designation for the treatment of Amyotrophic Lateral Sclerosis .
It's not like Tony Pucci, who is probably the area's most prolific songwriter, to ruminate over a CD.
ALS patient not ready to accept an end
There are three things that take my breath away: a beautiful woman, a gorgeous sunset and my illness.
Also on Topix